PCK1 and lung adenocarcinoma: Furthermore, it is noteworthy that in lung adenocarcinoma, KLF5 not only regulates the KLF5-MLK4-PCK1 signaling axis but also influences drug metabolism pathways associated with Cytochrome P450 enzymes, highlighting the importance and complexity of KLF5 in regulating lung adenocarcinoma development.